DE69015745D1 - NMDA-Antagonisten. - Google Patents

NMDA-Antagonisten.

Info

Publication number
DE69015745D1
DE69015745D1 DE69015745T DE69015745T DE69015745D1 DE 69015745 D1 DE69015745 D1 DE 69015745D1 DE 69015745 T DE69015745 T DE 69015745T DE 69015745 T DE69015745 T DE 69015745T DE 69015745 D1 DE69015745 D1 DE 69015745D1
Authority
DE
Germany
Prior art keywords
nmda antagonists
nmda
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69015745T
Other languages
English (en)
Other versions
DE69015745T2 (de
Inventor
Jeffrey P Whitten
Bruce M Baron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/553,431 external-priority patent/US5095009A/en
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of DE69015745D1 publication Critical patent/DE69015745D1/de
Application granted granted Critical
Publication of DE69015745T2 publication Critical patent/DE69015745T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/650952Six-membered rings having the nitrogen atoms in the positions 1 and 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE69015745T 1989-09-19 1990-09-19 NMDA-Antagonisten. Expired - Fee Related DE69015745T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40947889A 1989-09-19 1989-09-19
US50833390A 1990-04-11 1990-04-11
US07/553,431 US5095009A (en) 1990-04-11 1990-07-20 NMDA antagonists

Publications (2)

Publication Number Publication Date
DE69015745D1 true DE69015745D1 (de) 1995-02-16
DE69015745T2 DE69015745T2 (de) 1995-05-11

Family

ID=27410806

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69015745T Expired - Fee Related DE69015745T2 (de) 1989-09-19 1990-09-19 NMDA-Antagonisten.

Country Status (20)

Country Link
EP (1) EP0418863B1 (de)
JP (1) JP2934295B2 (de)
KR (2) KR100191116B1 (de)
CN (1) CN1027694C (de)
AR (2) AR247889A1 (de)
AT (1) ATE116653T1 (de)
AU (1) AU632362B2 (de)
CA (1) CA2025326C (de)
DE (1) DE69015745T2 (de)
DK (1) DK0418863T3 (de)
ES (1) ES2069644T3 (de)
FI (1) FI102613B1 (de)
GR (1) GR3015656T3 (de)
HU (1) HU207523B (de)
IE (1) IE65118B1 (de)
IL (1) IL95718A (de)
MX (1) MX9203696A (de)
NO (1) NO178375C (de)
NZ (1) NZ235322A (de)
PT (1) PT95344B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554773A (en) * 1991-11-15 1996-09-10 Merrell Pharmaceuticals Inc. N-trityl protected aspartic acid derivatives for the preparation of phosphonate NMDA antagonists
ES2087555T3 (es) * 1991-11-15 1996-07-16 Merrell Pharma Inc Derivados de acido n-tritilo aspartico utilizados para la preparacion de antagonistas de fosfonato nmda.
GB9325368D0 (en) * 1993-12-10 1994-02-16 Univ Bristol Organic compounds
EP0684238A3 (de) * 1994-04-27 1997-01-15 Hoffmann La Roche Verfahren zur Herstellung von Dicarboxamiden.
EP3427729A1 (de) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid zur behandlung von epileptischen erkrankungen, störungen oder zuständen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970684A (en) * 1973-07-06 1976-07-20 Syntex (U.S.A.) Inc. Polyunsaturated prostaglandin derivatives
CA1248531A (en) * 1984-04-17 1989-01-10 Jeffrey C. Watkins 4-substituted piperazine-2-carboxylic acids

Also Published As

Publication number Publication date
PT95344A (pt) 1991-06-25
FI102613B (fi) 1999-01-15
DK0418863T3 (da) 1995-03-20
IE65118B1 (en) 1995-10-04
DE69015745T2 (de) 1995-05-11
EP0418863A2 (de) 1991-03-27
PT95344B (pt) 1998-02-27
MX9203696A (es) 1992-09-01
EP0418863B1 (de) 1995-01-04
NO904061D0 (no) 1990-09-18
CN1027694C (zh) 1995-02-22
KR100191116B1 (ko) 1999-06-15
NO178375B (no) 1995-12-04
KR100196265B1 (ko) 1999-06-15
AU6247490A (en) 1991-03-28
GR3015656T3 (en) 1995-07-31
CA2025326A1 (en) 1991-03-20
CN1050387A (zh) 1991-04-03
IE903380A1 (en) 1991-04-10
ES2069644T3 (es) 1995-05-16
HU207523B (en) 1993-04-28
NZ235322A (en) 1993-02-25
HUT54699A (en) 1991-03-28
KR910006311A (ko) 1991-04-29
FI904588A0 (fi) 1990-09-18
ATE116653T1 (de) 1995-01-15
EP0418863A3 (en) 1991-06-12
AR248028A1 (es) 1995-05-31
AR247889A1 (es) 1995-04-28
NO904061L (no) 1991-03-20
CA2025326C (en) 2001-04-24
JPH03130295A (ja) 1991-06-04
FI102613B1 (fi) 1999-01-15
AU632362B2 (en) 1992-12-24
NO178375C (no) 1996-03-13
IL95718A (en) 1998-03-10
JP2934295B2 (ja) 1999-08-16

Similar Documents

Publication Publication Date Title
DE69020494D1 (de) Metrologie.
DE69002926D1 (de) Abgabevorrichtung.
FI890542A0 (fi) Staell foer handtelefon.
NO900054L (no) Dispenser.
DE69020982D1 (de) Vulkanisierungsform.
DE59003933D1 (de) Bauelement.
FI891064A (fi) Vattenreningsanlaeggning.
DE69022756D1 (de) Ausgabevorrichtung.
DE59009874D1 (de) Iminosilane.
DE69015745D1 (de) NMDA-Antagonisten.
FI901363A0 (fi) Tetrahydronaftalinderivat.
FI890299A (fi) Form.
DE59007719D1 (de) Pyrazol-3-carbonsäureamide.
FI895448A0 (fi) Antennsystem foer fordon.
FI891930A0 (fi) Elektromekanisk vinstfoerdelningsmaskineri foer spelautomater.
FI890300A (fi) Form.
FI890855A0 (fi) Skidstavstruga.
ES1010851Y (es) Mueble-bar.
FI890563A (fi) Under badandet anvaendbart redskap.
NO893672D0 (no) Engangsforskaling.
ES1009558Y (es) Chimenea-hogar.
FI890875A (fi) Dragslunga.
FI891171A0 (fi) Dammfritt sandblaestringssystem.
FI905394A0 (fi) Gloedlampsarmatur.
FI892916A (fi) Muffoerbindning.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee